It's no secret that a good night's sleep is key to a healthy brain. However, the full extent of the importance of rest on our ...

AI models from OpenAI, Anthropic, and other top AI labs are increasingly being used to assist with programming tasks. Google ...

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

New research reveals that a single night of sleep can enhance memory for the order of real-world experiences—lasting for over ...

While sleep’s positive impact on cognition has long been recognized, Baycrest researchers have revealed that a good night’s ...

Rhythm Pharmaceuticals met phase 3 endpoint for treating hypothalamic obesity, with regulatory submissions planned for 2025.

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

IPAX-Linz is a single-arm Phase 2 investigator-initiated trial (IIT). IPAX-Linz evaluates the safety, tolerability and preliminary efficacy of TLX101 therapy, in combination with external beam ...

Telix Pharmaceuticals Limited, today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 in recurrent ...

LCGC International spoke to Lauren Lovejoy, principal scientist in the Drug Substance and Product Analysis group at GSK ...